These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26278971)

  • 1. Application of Organ Clearance to Estimation of the In Vivo Hepatic Extraction Ratio.
    Mehvar R
    Curr Clin Pharmacol; 2016; 11(1):47-52. PubMed ID: 26278971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. After 50 Years of Hepatic Clearance Models, Where Should We Go from Here? Improvements and Implications for Physiologically Based Pharmacokinetic Modeling.
    Pang KS; Lu WI; Mulder GJ
    Drug Metab Dispos; 2024 Jul; 52(8):919-931. PubMed ID: 39013583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein binding and drug clearance.
    Rowland M
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():10-7. PubMed ID: 6705422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the Systemic Plasma Profile Inform the Liver Profile? Analysis Using a Physiologically Based Pharmacokinetic Model and Individual Compounds.
    Li R; Maurer TS; Sweeney K; Barton HA
    AAPS J; 2016 May; 18(3):746-56. PubMed ID: 26951483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered hepatic blood flow and drug disposition.
    Nies AS; Shand DG; Wilkinson GR
    Clin Pharmacokinet; 1976; 1(2):135-55. PubMed ID: 13954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the prediction of hepatic clearance using the diluted plasma in metabolic stability assay.
    Berezhkovskiy LM; Khojasteh SC; Halladay JS; Hop CE
    J Pharm Sci; 2009 Jun; 98(6):1922-7. PubMed ID: 18837013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
    Imawaka H; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
    Varma MV; El-Kattan AF
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S99-S109. PubMed ID: 27385183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The corrected traditional equations for calculation of hepatic clearance that account for the difference in drug ionization in extracellular and intracellular tissue water and the corresponding corrected PBPK equation.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Mar; 100(3):1167-83. PubMed ID: 21355107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methods for studying the hepatic metabolism of drugs in man].
    Geneve J; Bergmann JF; Caulin C; Segrestaa JM
    Therapie; 1990; 45(2):91-7. PubMed ID: 2191470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considering Age Variation When Coining Drugs as High versus Low Hepatic Extraction Ratio.
    Salem F; Abduljalil K; Kamiyama Y; Rostami-Hodjegan A
    Drug Metab Dispos; 2016 Jul; 44(7):1099-102. PubMed ID: 26864786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of dye infusion rate and hepatic plasma flow on indocyanine green clearance.
    Krarup N; Larsen JA
    Scand J Clin Lab Invest; 1976 Mar; 36(2):183-8. PubMed ID: 1273495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling and predicting drug pharmacokinetics in patients with renal impairment.
    Rowland Yeo K; Aarabi M; Jamei M; Rostami-Hodjegan A
    Expert Rev Clin Pharmacol; 2011 Mar; 4(2):261-74. PubMed ID: 22115405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.
    Rane A; Wilkinson GR; Shand DG
    J Pharmacol Exp Ther; 1977 Feb; 200(2):420-4. PubMed ID: 839445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of halothane on drug disposition: contribution of changes in intrinsic drug metabolizing capacity and hepatic blood flow.
    Reilly CS; Wood AJ; Koshakji RP; Wood M
    Anesthesiology; 1985 Jul; 63(1):70-6. PubMed ID: 4014773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.